46 results on '"Elia, Alessia"'
Search Results
2. How do system-wide net-zero scenarios compare to sector model pathways for the EU? A novel approach based on benchmark indicators and index decomposition analyses
3. Reinforcing the Paris Agreement: Ambitious scenarios for the decarbonisation of the Central Asian and Caspian region
4. Heterogeneity across outcomes reported in clinical trials for older adults with depression: a systematic survey
5. Where is the EU headed given its current climate policy? A stakeholder-driven model inter-comparison
6. Primary outcome reporting in clinical trials for older adults with depression
7. Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis
8. Genetic basis of cannabis use: a systematic review
9. Delirium and other neuropsychiatric manifestations of COVID-19 infection in people with preexisting psychiatric disorders: a systematic review
10. A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder
11. GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol
12. Genetic determinants of cannabis use: a systematic review protocol
13. Feasibility of behavioral activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial
14. The interplay among COVID-19 economic recovery, behavioural changes, and the European Green Deal: An energy-economic modelling perspective
15. A Multi-Model Analysis of the EU's Path to Net Zero: Aligning Near-Term Action with Long-Term Visions
16. The interplay among COVID-19 economic recovery, behavioural changes, and the European Green Deal: An energy-economic modelling perspective
17. Global pathways & EU response: A 2nd European Regional, National and Sectoral assessment
18. USING MOTIVATION TO UNDERSTAND TREATMENT AND DECISION-MAKING IN PSYCHIATRIC ILLNESS
19. Reinforcing the Paris Agreement: Ambitious Scenarios for the Decarbonisation of the Central Asian and Caspian Region
20. Identifying patient-important outcomes for treatment of bipolar disorder: a systematic review protocol
21. Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis
22. Outcomes reported in randomised controlled trials of major depressive disorder in older adults: protocol for a methodological review
23. The Role of Perceived Social Support in the Association Between Stressful Life Events and Suicidal Behavior
24. Additional file 1 of Genetic basis of cannabis use: a systematic review
25. Additional file 1 of Delirium and other neuropsychiatric manifestations of COVID-19 infection in people with preexisting psychiatric disorders: a systematic review
26. Additional file 2 of Delirium and other neuropsychiatric manifestations of COVID-19 infection in people with preexisting psychiatric disorders: a systematic review
27. The future of precision medicine in opioid use disorder: inclusion of patient-important outcomes in clinical trials
28. Association between vaping and health outcomes in patients with opioid use disorder: a systematic review protocol
29. Mobile Applications for COVID-19: A Scoping Review of the Initial Response in Canada
30. Treatment Outcomes in Patients With Opioid Use Disorder Who Were First Introduced to Opioids by Prescription: A Systematic Review and Meta-Analysis
31. Mobile Applications for COVID-19: A Scoping Review
32. The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study
33. Additional file 2 of Genetic determinants of cannabis use: a systematic review protocol
34. Quantifying the impact of energy technology innovation on cost reductions
35. The association between health conditions and cannabis use in patients with opioid use disorder receiving methadone maintenance treatment
36. Feasibility of behavioral activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial.
37. Adverse Outcomes Associated with Prescription Opioids for Acute Low Back Pain: A Systematic Review and Meta-Analysis.
38. Additional file 1 of Genetic determinants of cannabis use: a systematic review protocol
39. Additional file 1 of Genetic determinants of cannabis use: a systematic review protocol
40. Additional file 1 of GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol
41. Additional file 1 of A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder
42. Additional file 1 of GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol
43. Additional file 1 of Feasibility of behavioral activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial
44. Additional file 1 of A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder
45. Additional file 1 of Feasibility of behavioral activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial
46. The future of precision medicine in opioid use disorder: inclusion of patient-important outcomes in clinical trials.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.